Consistent with those findings, the results of the present study show that systemic treatment with EMPmiR-19b aggravated arterial atherosclerosis in ApoE-/- mice as manifested by higher carotid flow resistance, decreased carotid artery diameter, larger atherosclerotic plaques, and increased instability of plaques with a thinner fibrous cap. This evidence concerns the gene APOE and atherosclerosis.